P. Rümke

发表

Adjuvant reactivity predicts survival in patients with “high‐risk” primary malignant melanoma treated with systemic BCG

M. Buyse, A. Cochran, E. Macher, 1981, International journal of cancer.

An assessment of DTIC versus levamisole or placebo in the treatment of high risk stage I patients after surgical removal of a primary melanoma of the skin. A phase III adjuvant study. EORTC protocol 18761

U. Kleeberg, S. Suciu, E. Macher, 1988 .

Cytotoxic lymphocytes in melanoma patients

J. Bernheim, J. D. de Vries, P. Rümke, 1972 .

The eortc melanoma group exchange program: Evaluation of a multicenter monoclonal antibody study

E. Bröcker, U. Kleeberg, J. Doré, 1991, International journal of cancer.

A monoclonal antibody specific for cells of the melanocyte lineage.

D. Ruiter, J. Calafat, P. Rümke, 1988, The American journal of pathology.

Patients' and doctors' delay in the diagnosis and treatment of cutaneous melanoma.

A. Hart, P. Rümke, F. Rampen, 1989, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Clinical features of superficial spreading melanomas with zones of regression

E. Bröcker, B. Czarnetzki, E. Macher, 2005, Journal of Cancer Research and Clinical Oncology.

Tamoxifen as a single agent for advanced melanoma in postmenopausal women. A phase II study of the EORTC Malignant Melanoma Cooperative Group

E. Bröcker, R. MacKie, U. Kleeberg, 1992, Melanoma research.

Characterization of melanoma‐associated surface antigens involved in the adhesion and motility of human melanoma cells

C. Figdor, D. Ruiter, A. T. Te Velde, 1986, International journal of cancer.

Antibodies against human T‐cell leukemia/lymphoma virus (HTLV) and expression of HTLV p19 antigen in relatives of a T‐cell leukemia patient originating from Surinam

M. Robert-Guroff, R. Gallo, F. Vyth-Dreese, 1983, International journal of cancer.

Sperm-agglutinating autoantibodies in relation to male infertility.

P. Rümke, 1968, Proceedings of the Royal Society of Medicine.

Immunohistochemical and histochemical tools in the diagnosis of amelanotic melanoma

D. Ruiter, S. V. van Duinen, P. Rümke, 1984, Cancer.

Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody

S. Rodenhuis, C. Melief, J. Sein, 2005, Cancer Immunology, Immunotherapy.

A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma

N. Cascinelli, G. Bonadonna, U. Veronesi, 1982 .

Spermagglutinin formation in male rats by subcutaneously injected syngeneic epididymal spermatozoa and by vasoligation or vasectomy.

P. Rümke, M. Titus, 1970, Journal of reproduction and fertility.

Lymph node metastasis from melanoma with an unknown primary site

A. Hart, W. Mooi, J. V. Dongen, 1990, The British journal of surgery.

Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanoma.

A. Hart, L. Strobbe, B. Kroon, 1997 .

Biochemical characterization and cellular localization of a formalin‐resistant melanoma‐associated antigen reacting with monoclonal antibody NKI/C‐3

A. Kolk, J. Calafat, H. Janssen, 1985, International journal of cancer.

Prevalence of HTLV-specific antibodies in Surinam emigrants to The Netherlands.

M. Robert-Guroff, R. Coutinho, F. Vyth-Dreese, 1984, Leukemia research.

Sister chromatid exchanges, hyperdiploidy and chromosomal rearrangements studied in cells from melanoma-prone individuals belonging to families with the dysplastic nevus syndrome.

N. Jaspers, P. Rümke, J. Van Hemel, 1987, Cancer genetics and cytogenetics.

SERUM α-FETOPROTEIN IN INDONESIA

P. Rümke, S. B. Kresno, R. Gandasoebrata, 1970 .

Antibodies and antigen expression in human melanoma detected by the immune adherence test

John G. Collard, J. D. de Vries, P. Rümke, 1975, International journal of cancer.

The influence of different isolation procedures and the use of target cells from melanoma cell lines and short‐term cultures on the non‐specific cytotoxic effects of lymphocytes from healthy donors

J. D. de Vries, P. Rümke, A. van Dongen, 1975, International journal of cancer.

Effects of systemic interferon-alpha (IFN-alpha) on the antigenic phenotype of melanoma metastases. EORTC melanoma group cooperative study No. 18852.

E. Bröcker, P. Rümke, M. von Depka Prondzinski, 1993, Melanoma research.

Tumour‐associated lymphocyte cytotoxicity superimposed on “Spontaneous” cytotoxicity in melanoma patients

J. D. de Vries, P. Rümke, 1976, International journal of cancer.

Cytotoxity of non‐T versus T‐lymphocytes from melanoma patients and healthy donors on short‐ and long‐term cultured melanoma cells

J. D. de Vries, P. Rümke, S. Cornain, 1974, International journal of cancer.

Post-vasectomy autoimmunity to protamines in relation to the formation of granulomas and sperm agglutinating antibodies.

P. Rümke, L. Linnet, T. Samuel, 1978, Clinical and experimental immunology.

Autoimmunity to sperm antigens in vasectomized men.

A. Kolk, J. M. van Lis, P. Rümke, 1975, Clinical and experimental immunology.

The antigens of human seminal plasma. With special reference to lactoferrin as a spermatozoa-coating antigen.

A. Hekman, P. Rümke, 1969, Fertility and sterility.

The micro-sperm immobilization test: the use of only motile spermatozoa and studies of complement.

P. Rümke, H. Hellema, 1978, Clinical and experimental immunology.

Monkey (Macaca speciosa) antisera against melanoma

P. Rümke, C. Vennegoor, A. V. Es, 1982, Cancer Immunology, Immunotherapy.

Autoimmunity against sperms in infertile men.

P. Rümke, 1984, Asian Pacific journal of allergy and immunology.

Circulating melanoma-associated antigen detected by monoclonal antibody NKI/C-3

P. Rümke, C. Vennegoor, 2004, Cancer Immunology, Immunotherapy.

The Use of Chemotherapy in the Management of Patients with Malignant Melanoma

P. Rümke, 1984 .

Oestrogen and androgen receptors in melanoma.

J. Persijn, P. Rümke, C. B. Korsten, 1980, British Journal of Cancer.

Immunotherapy of cancer.

P. Rümke, 1971, The Medical journal of Australia.

Detection of Antibodies against Mitochondria by the Fluorescent Antibody Technique with Smears of Rat Liver Cells

P. Rümke, H. Buter, 1967, Nature.

AUTOSPERMAGGLUTININS: IMMUNOFLUORESCENT STUDIES

N. Ladiges, T. Feltkamp, P. Rümke, 1965, Annals of the New York Academy of Sciences.

Prognosis of fertility in women with unexplained infertility and sperm agglutinins in the serum.

P. Bezemer, P. Rümke, C. Renckens, 1984, Fertility and sterility.

Immune sperm agglutination: are only motile spermatozoa involved?

P. Rümke, H. Hellema, 1978, Clinical and experimental immunology.

N-(phosphonacetyl)-L-aspartate (PALA) in advanced malignant melanoma: a phase II trial of the EORTC Malignant Melanoma Cooperative Group.

J. Mulder, U. Kleeberg, M. Rozencweig, 1982, European journal of cancer & clinical oncology.

Radio-immuno assay of lactoferrin in blood plasma of breast cancer patients, lactating and normal women; prevention of false high levels caused by leakage from neutrophile leucocytes in vitro.

A. Hart, P. Rümke, H. G. Kwa, 1971, Folia medica Neerlandica.

Auto- and isoimmunity to sperm in infertility

A. Hekman, P. Rümke, 1975 .

Potentiation by interleukin 2 of Burkitt's lymphoma therapy with anti-pan B (anti-CD19) monoclonal antibodies in a mouse xenotransplantation model.

A. Hekman, M. D. de Rie, C. Melief, 1989, Cancer research.

[Revised consensus melanoma of the skin].

D. Ruiter, B. Kroon, P. Rümke, 1990, Nederlands tijdschrift voor geneeskunde.

[Consensus melanoma of the skin].

P. Rümke, F. Rampen, 1985, Nederlands tijdschrift voor geneeskunde.

Studies on hormones from the anterior pituitary gland. I. Identification and isolation of growth hormone and prolactin from the "granular" fraction of bovine pituitary.

P. Rümke, C. Feltkamp, H. Bloemendal, 1965, Biochimica et biophysica acta.

How to Enhance the Sensitivity of the Radial Single Diffusion Technique for the Quantitation of Antigens

P. Rümke, J. C. Breekveldt-Kielich, J. C. Breekveldt‐Kielich, 1969, Vox sanguinis.

Sex-associated urinary protein in the rat.

P. Rümke, J. C. Breekveldt-Kielich, A. van Broecke-Siddré, 1970, Biochimica et biophysica acta.

Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC Protocol 18781).

P. Steerenberg, S. Suciu, E. Macher, 1993, European journal of cancer.

Consensus on the management of melanoma of the skin in The Netherlands. Dutch Melanoma Working Party.

P. Rümke, J. van Everdingen, 1992, European journal of cancer.

Prognostic value of tuberculin and BCG immunoreactivity in stage I high-risk malignant melanoma (EORTC protocol 18781).

E. Bröcker, P. Steerenberg, S. Suciu, 1996, Dermatology.

EORTC phase II trial of vindesine in advanced melanoma.

J. Mulder, M. Rozencweig, P. Rümke, 1983, European journal of cancer & clinical oncology.

The significance of conversion of skin reactivity to efficacy of bacillus Calmette-Guérin (BCG) vaccinations given immediately after radical surgery in stage II melanoma patients

N. Cascinelli, A. Morabito, R. MacKie, 2004, Cancer Immunology, Immunotherapy.

Studies on the immunogenicity of protamines in humans and experimental animals by means of a micro-complement fixation test.

A. Kolk, P. Rümke, T. Samuel, 1978, Clinical and experimental immunology.

Combined treatment with radiation and hyperthermia in metastatic malignant melanoma.

L. Blank, D. González, P. Rümke, 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Humoral immune response in disease-free advanced melanoma patients after vaccination with melanoma-associated gangliosides. EORTC Cooperative Melanoma Group.

J. Doré, P. Rümke, J. Portoukalian, 1991, International journal of cancer.

Satellite and in-transit (SIT) metastases from melanoma are more predominant in females than in males.

P. Rümke, F. Rampen, S. Menzel, 1987, Anticancer research.

Results of radical dissection of the groin in patients with stage II melanoma and histologically proved metastases of the iliac or obturator lymph nodes, or both.

A. Hart, B. Kroon, P. Rümke, 1988, Surgery, gynecology & obstetrics.

Concurrent cis-diamminedichloroplatinum(II) and radiation treatment for melanoma metastases: a pilot study.

H. Bartelink, L. Dewit, P. Rümke, 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The origin of immunoglobulins in semen.

P. Rümke, 1974, Clinical and experimental immunology.

Comparative immunochemical studies with antisera to sheep prolactin and bovine growth hormone on anterior pituitaries of ox, sheep, rats and mice

N. Ladiges, P. Rümke, 1965, Zeitschrift für Zellforschung und Mikroskopische Anatomie.

[Comparative clinical study of pyogenic granuloma and amelanotic melanoma of the skin].

P. Rümke, F. Rampen, J. V. van Everdingen, 1985, Nederlands tijdschrift voor geneeskunde.

Sperm autoantibodies as a consequence of vasectomy. I. Within 1 year post-operation.

P. Rümke, H. Hellema, 1978, Clinical and experimental immunology.

Comparison of the tray agglutination technique with the gelatin agglutination technique for the detection of spermagglutinating activity in human sera.

P. Rümke, H. Hellema, 1976, Fertility and sterility.

Auto- and iso-antibodies to antigens of the human reproductive system. 1. Results of an international comparative study of antibodies to spermatozoa and other antigens detected in sera from infertile patients deposited in the WHO Reference Bank for Reproductive Immunology.

P. Rümke, S. Shulman, B. Boettcher, 1977, Acta pathologica et microbiologica Scandinavica. Supplement.

A test for the detection of cytotoxic antibodies to spermatozoa in man.

P. Rümke, J. Hamerlynck, 1968, Journal of reproduction and fertility.

AUTOSPERMAGGLUTININS: A CAUSE OF INFERTILITY IN MEN

P. Rümke, 1965, Annals of the New York Academy of Sciences.

A fertile man with a high sperm agglutination titer in the seminal plasma: a case report.

P. Rümke, J. Kremer, S. Jager, 1987, American journal of reproductive immunology and microbiology : AJRIM.

Histone and DNA detection in swollen spermatozoa and somatic cells, by immunofluorescence.

M. Bustin, A. Kolk, L. Aarden, 1976, Clinical and experimental immunology.

Sterility: an immunologic disorder?

A. Hekman, P. Rümke, 1977, Clinical obstetrics and gynecology.

Referral pattern and accuracy of clinical diagnosis of cutaneous melanoma.

F H Rampen, P. Rümke, P Rümke, 1988, Acta dermato-venereologica.

Tumour markers, impact and prospects

E. Boelsma, P. Rümke, 1979 .

Anticytoplasmic auto-antibodies in a patient with signs of tumour resistance.

P. Rümke, 1965, European journal of cancer.

Antigenicity of histones: comparative studies on histones with very high lysine content from various sources.

A. Hekman, P. Rümke, M. Sluyser, 1969, Immunochemistry.

Antigenicity of histones.

P. Rümke, M. Sluyser, 1966, The Biochemical journal.

Aerosol application of interferon-alpha in the treatment of bronchioloalveolar carcinoma.

E. Jassem, N. van Zandwijk, N. Zandwijk, 1990, European journal of cancer.

Auto-antigens of human spermatozoa. I. Solubilization of a new auto-antigen detected on swollen spermheads.

A. Kolk, P. Rümke, T. Samuel, 1974, Clinical and experimental immunology.

Effect of BCG Stimulation on the Growth Rate of Pulmonary Metastases in 3 Patients with Melanoma

J. Bernheim, P. Rümke, D. V. D. Vorm, 1974 .

A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma.

N. Cascinelli, G. Bonadonna, U. Veronesi, 1982, The New England journal of medicine.

Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanoma

B. Kroon, P. Rümke, L. Strobbe, 1997, Melanoma research.

Effects of mixtures and complexes of chlorambucil and antibody on a human melanoma cell line.

P. Rümke, C. Vennegoor, D. Van Smeerdijk, 1975, European journal of cancer.